CLX

insider transactions

CLOROX CO /DE/ — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Other·F
Apr 1, 26

Luc Bellet KEY

EVP - Chief Financial Officer

$25.3K

244 sh · $103.63

Own -1%
Grant·A
Mar 31, 26

Christopher J Williams

Director

$0

265 sh

Own +1%
Grant·A
Mar 31, 26

Russell J Weiner

Director

$0

326 sh

Own +2%
Grant·A
Mar 31, 26

Matthew J Shattock

Director

$0

507 sh

Own +3%
Grant·A
Mar 31, 26

Stephanie Plaines

Director

$0

265 sh

Own +4%
Other·F
Mar 13, 26

Chris T Hyder

EVP-Group Pres -Hlth & Hyg

$4.5K

41 sh · $108.73

Own -0%
Other·F
Mar 13, 26

Stacey Grier

EVP - Executive Chief of Staff

$3.5K

32 sh · $108.73

Own -0%
Grant·A
Feb 13, 26

Christopher J Williams

Director

$0

213 sh

Own +1%
Grant·A
Feb 13, 26

Russell J Weiner

Director

$0

172 sh

Own +1%
Grant·A
Feb 13, 26

Matthew J Shattock

Director

$0

191 sh

Own +1%
Grant·A
Feb 13, 26

Stephanie Plaines

Director

$0

73 sh

Own +1%
Grant·A
Dec 31, 25

Christopher J Williams

Director

$0

273 sh

Own +1%
Grant·A
Dec 31, 25

Christopher J Williams

Director

$0

1.6K sh

Own +8%
Grant·A
Dec 31, 25

Russell J Weiner

Director

$0

335 sh

Own +2%
Grant·A
Dec 31, 25

Russell J Weiner

Director

$0

1.6K sh

Own +11%
Grant·A
Dec 31, 25

Matthew J Shattock

Director

$0

521 sh

Own +3%
Grant·A
Dec 31, 25

Matthew J Shattock

Director

$0

1.6K sh

Own +9%
Grant·A
Dec 31, 25

Stephanie Plaines

Director

$0

273 sh

Own +4%
Grant·A
Dec 31, 25

Stephanie Plaines

Director

$0

1.6K sh

Own +30%
Grant·A
Dec 31, 25

A D David Mackay

Director

$0

1.6K sh

Own +17%
Grant·A
Dec 31, 25

Esther Lee

Director

$0

1.6K sh

Own +12%
Grant·A
Dec 31, 25

Spencer C Fleischer

Director

$0

145 sh

Own +1%
Grant·A
Dec 31, 25

Spencer C Fleischer

Director

$0

1.2K sh

Own +6%
Grant·A
Dec 31, 25

Julia Charter

Director

$0

1.6K sh

Own +58%
Grant·A
Dec 31, 25

Gina Boswell

Director

$0

825 sh

Own New
Grant·A
Nov 6, 25

Christopher J Williams

Director

$0

227 sh

Own +1%
Grant·A
Nov 6, 25

Russell J Weiner

Director

$0

179 sh

Own +1%
Grant·A
Nov 6, 25

Matthew J Shattock

Director

$0

199 sh

Own +1%
Grant·A
Nov 6, 25

Stephanie Plaines

Director

$0

63 sh

Own +1%
Grant·A
Nov 6, 25

A D David Mackay

Director

$0

109 sh

Own +1%
Grant·A
Nov 6, 25

Esther Lee

Director

$0

162 sh

Own +1%
Grant·A
Nov 6, 25

Spencer C Fleischer

Director

$0

219 sh

Own +1%
Grant·A
Nov 6, 25

Julia Charter

Director

$0

33 sh

Own +1%
Grant·A
Aug 29, 25

A D David Mackay

Director

$0

97 sh

Own +1%
Grant·A
Aug 29, 25

Esther Lee

Director

$0

144 sh

Own +1%
Grant·A
Aug 29, 25

Julia Charter

Director

$0

29 sh

Own +1%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Apr 1, 2026	Luc Bellet KEY	EVP - Chief Financial Officer	Other F	244	-1%	$103.63	$25.3K
Mar 31, 2026	Christopher J Williams	Director	Grant A	265	+1%	—	$0
Mar 31, 2026	Russell J Weiner	Director	Grant A	326	+2%	—	$0
Mar 31, 2026	Matthew J Shattock	Director	Grant A	507	+3%	—	$0
Mar 31, 2026	Stephanie Plaines	Director	Grant A	265	+4%	—	$0
Mar 13, 2026	Chris T Hyder	EVP-Group Pres -Hlth & Hyg	Other F	41	-0%	$108.73	$4.5K
Mar 13, 2026	Stacey Grier	EVP - Executive Chief of Staff	Other F	32	-0%	$108.73	$3.5K
Feb 13, 2026	Christopher J Williams	Director	Grant A	213	+1%	—	$0
Feb 13, 2026	Russell J Weiner	Director	Grant A	172	+1%	—	$0
Feb 13, 2026	Matthew J Shattock	Director	Grant A	191	+1%	—	$0
Feb 13, 2026	Stephanie Plaines	Director	Grant A	73	+1%	—	$0
Dec 31, 2025	Christopher J Williams	Director	Grant A	273	+1%	—	$0
Dec 31, 2025	Christopher J Williams	Director	Grant A	1.6K	+8%	—	$0
Dec 31, 2025	Russell J Weiner	Director	Grant A	335	+2%	—	$0
Dec 31, 2025	Russell J Weiner	Director	Grant A	1.6K	+11%	—	$0
Dec 31, 2025	Matthew J Shattock	Director	Grant A	521	+3%	—	$0
Dec 31, 2025	Matthew J Shattock	Director	Grant A	1.6K	+9%	—	$0
Dec 31, 2025	Stephanie Plaines	Director	Grant A	273	+4%	—	$0
Dec 31, 2025	Stephanie Plaines	Director	Grant A	1.6K	+30%	—	$0
Dec 31, 2025	A D David Mackay	Director	Grant A	1.6K	+17%	—	$0
Dec 31, 2025	Esther Lee	Director	Grant A	1.6K	+12%	—	$0
Dec 31, 2025	Spencer C Fleischer	Director	Grant A	145	+1%	—	$0
Dec 31, 2025	Spencer C Fleischer	Director	Grant A	1.2K	+6%	—	$0
Dec 31, 2025	Julia Charter	Director	Grant A	1.6K	+58%	—	$0
Dec 31, 2025	Gina Boswell	Director	Grant A	825	New	—	$0
Nov 6, 2025	Christopher J Williams	Director	Grant A	227	+1%	—	$0
Nov 6, 2025	Russell J Weiner	Director	Grant A	179	+1%	—	$0
Nov 6, 2025	Matthew J Shattock	Director	Grant A	199	+1%	—	$0
Nov 6, 2025	Stephanie Plaines	Director	Grant A	63	+1%	—	$0
Nov 6, 2025	A D David Mackay	Director	Grant A	109	+1%	—	$0
Nov 6, 2025	Esther Lee	Director	Grant A	162	+1%	—	$0
Nov 6, 2025	Spencer C Fleischer	Director	Grant A	219	+1%	—	$0
Nov 6, 2025	Julia Charter	Director	Grant A	33	+1%	—	$0
Aug 29, 2025	A D David Mackay	Director	Grant A	97	+1%	—	$0
Aug 29, 2025	Esther Lee	Director	Grant A	144	+1%	—	$0
Aug 29, 2025	Julia Charter	Director	Grant A	29	+1%	—	$0

About CLX insider trading

This page tracks insider transactions for CLOROX CO /DE/ (CLX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.